Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]
2007
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007
Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
2004 Standout
The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease
2011 Standout
Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial
2010
Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
2010
Blood Pressure as an Independent Prognostic Factor in Acute Ischemic Stroke
2006
Computed Tomography Perfusion Imaging in the Selection of Acute Stroke Patients to Undergo Emergent Carotid Endarterectomy
2014
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Intracerebral haemorrhage
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial
2010
Optimizing Blood Pressure in Neurological Emergencies
2004
Haemodilution for acute ischaemic stroke
2002
Blood pressure as a prognostic factor after acute stroke
2009
Systemic blood pressure and stroke outcome and recurrence
2005
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
2011
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
2011
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
High Blood Pressure as Risk Factor and Prognostic Predictor in Acute Ischaemic Stroke: When and How to Treat It?
2003
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Severe Sepsis and Septic Shock
2013 Standout
Lisinopril for the Treatment of Hypertension Within the First 24 Hours of Acute Ischemic Stroke and Follow-Up
2007
The management of blood pressure in acute stroke
2003
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension
2004
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Systemic blood pressure and stroke outcome and recurrence
2004
Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
2001
Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)
2007
Stroke
2008 Standout
Bendrofluazide Fails to Reduce Elevated Blood Pressure Levels in the Immediate Post-Stroke Period
2005
Sepsis and septic shock
2018 Standout
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
2009
Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial
2008
Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study
2002
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia
2005
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Early Recurrence of Ischemic Stroke in Japanese Patients: The Japan Standard Stroke Registry Study
2007
Physiology of Local Renin-Angiotensin Systems
2006 Standout
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal
2009
Is the normalisation of blood pressure in bleeding trauma patients harmful?
2001
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
2011
5-y Follow-up Study of Patients with Neuroborreliosis
2002
Subacute Recanalization and Reocclusion in Patients with Acute Ischemic Stroke Following Endovascular Treatment
2008
The Pathobiology of Vascular Dementia
2013 Standout
Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial
2006
Fluid challenge revisited
2006
Lyme borreliosis
2011 Standout
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Chronic Kidney Disease
2016 Standout
Multiple sclerosis
2002 Standout
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
2003
Blood Pressure Management in Patients With Acute Ischemic Stroke
2004
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Parenteral fluid regimens for improving functional outcome in people with acute stroke
2015
Initial emergency department blood pressure as predictor of survival after acute ischemic stroke
2005
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Guidelines for the Early Management of Patients With Ischemic Stroke
2005
Acute Hypertensive Response in Patients With Stroke
2008
High Blood Pressure in Acute Stroke and Subsequent Outcome
2003
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design
2005
Interventions for deliberately altering blood pressure in acute stroke
2014
Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion
2010
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
2011
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Ischemia Triggered by Red Blood Cell Products in the Subarachnoid Space Is Inhibited by Nimodipine Administration or Moderate Volume Expansion/Hemodilution in Rats
2002
Acute stroke: evaluation and treatment.
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Volume Replacement in Critically Ill Patients with Acute Renal Failure
2001
Ischemia Triggered by Red Blood Cell Products in the Subarachnoid Space Is Inhibited by Nimodipine Administration or Moderate Volume Expansion/Hemodilution in Rats
2002
COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design
2005
Recommendations for the Management of Cerebral and Cerebellar Infarction With Swelling
2014
Unimolecular Micelles based on Hydrophobically Derivatized Hyperbranched Polyglycerols: Biodistribution Studies
2008
Role of Transcranial Doppler Monitoring in the Diagnosis of Cerebral Vasospasm after Subarachnoid Hemorrhage
1999
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Prevention of Stroke and Myocardial Infarction by Amlodipine and Angiotensin Receptor Blockers
2007
Guidelines for the Early Management of Patients With Ischemic Stroke
2003
Effect of Blood Pressure Lowering in Early Ischemic Stroke
2015
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Study and treatment of post Lyme disease (STOP-LD)
2003
International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke.
2003
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Modest Blood Pressure Reduction with Valsartan in Acute Ischemic Stroke: A Prospective, Randomized, Open-Label, Blinded-End-Point Trial
2015
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
2017
Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke
2009
Works of J. Treib being referenced
Neurologic manifestation and classification of borreliosis
1996
An international view of hydroxyethyl starches
1999
Treatment of stroke on an intensive stroke unit: a novel concept
2000
Influence of a Long-Term, High-Dose Volume Therapy with 6% Hydroxyethyl Starch 130/0.4 or Crystalloid Solution on Hemodynamics, Rheology and Hemostasis in Patients with Acute Ischemic Stroke
2003
Transcranial Doppler Monitoring of Intracranial Pressure Therapy with Mannitol, Sorbitol and Glycerol in Patients with Acute Stroke
1998
Treatment with anticoagulants in cerebral events (TRACE)
2004
Cardiac output in patients with acute stroke
1996
Hemodynamics of stroke patients under therapy with low molecular weight hydroxyethyl starch
1998
All medium starches are not the same: Influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation
1996
Highly Substituted Hydroxyethyl Starch (HES 200/0.62) Leads to Type-l von Willebrand Syndrome after Repeated Administration
1996
Coagulation Disorders Caused by Hydroxyethyl Starch
1997
Clinical and serologic follow-up in patients with neuroborreliosis
1998
Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis
2001
Influence of Long-term Volume Therapywith Hydroxyethyl Starch on Leukocytes in Patients with Acute Stroke
2011
Influence of blood pressure and cardiac output on cerebral blood flow and autoregulation in acute stroke measured by TCD
1996
HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
1995
The ACCESS Study
2003
Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study
2001
HES 200/0.5 Is not HES 200/0.5
1995